|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�괯 |
|
ɱ��� |
| ��������������� | |
|
����÷ |
|
��־ǿ |
| PubMed | |
|
Article by |
|
Article by |
�ڷ���ά�������ƽ괯
����÷, ��־ǿ
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
��ά������һ�ֹ����������Ⱦҩ��,�½�������������괯.���Կڷ���ҩ,��Ч�ɿ�,��ȫ�Ժ�.�����ƽ괯��ɱ�����,��Ψһ����ϵͳӦ�õ�ҩ��,����ҩ�����á�ҩ������ѧ���ٴ�Ӧ�ü���ȫ�Խ����˼�Ҫ����.
[2] Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol, 2000,42(2 Pt 1):236-240.
[3] Chouela EN, Abeldano AM, Pellerano G, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermtol, 1999,135(6): 651-655.
[4] Cully DF, Vassilatis DK, Liu KK, et al. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature,1994, 371(6499): 707-711.
[5] Arena JP, Liu KK, Paress PS, et al. The mechanism of action of avermectins in Caenofrhabditis elegans: correlation between activation of glutamate-sensitive chloride current, membrane binding, and biological activity.J Parasitol, 1995, 81(2): 286-294.
[6] Hardman JL, et al. The Pharmacoogical basis of therapeutics. 9th ed. Xian: World Publishing Corporation, 1996. 1017-1018.
[7] Schinkel AH, Smit JJ, van Tellingen O, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 1994,77(4):491-502.
[8] Meinking TL, Taplin D, Hermida JL,et al. The treatment of scabies with ivermectin.N Engl J Med, 1995,333(1):26-30.
[9] Leppard B, Naburi AE. The use of ivermectin in controlling an outbreak of scabies in a prion. Br J Deratol,2000,143(3): 520-523.
[10] Elmogy M, Fayed H, Marzok H, et al. Oral ivermectin in the treatment of scabies.Int J Dermatol, 1999,38(12): 926-928.
[11] Aubin F, Humbert P. Ivermectin for crusted (Norwegion) scabies. N Engl J Med, 1995, 332(9): 612.
[12] Gladstone HB, Darmstadt GL. Crusted scabies in an immunocompetent child: treatment with ivermectin. Pediatr Dermtol, 2000, 17 (2): 144-148.
[13] Cestari SC, Petri V, Rotta O,et al. Oral treatment of crusted scabies with ivermectin: report of two cases. Pediatr Dermatol,2000, 17(5): 410-414.
[14] DelGiudice P, Carles M, Couppie P, et al. Successful treatment of crusted (Norwegian) scabies with ivermectin in two patients with human immunodeficiency virus infection. Br J Dermatol, 1996,135(3): 494-495.
[15] Dourmishev AL, Serafiimova DK, Donrmishev LA, et al. Crusted scabies of the scalp in dermatomyositis patients: three cases treated with oral ivermectin. Int J Dermatol, 1998,37(3):231-234.
[16] Gardon J, Gardon-Wendel N, Demanga-Ngangue, et al.Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet, 1997, 350(9070): 18-22.
[17] Burkhart CG, Burkhart CN, Burkhart KM. An epidemiologic and therapeutic reassessment of scabies. Curis, 2000,65(4):233-240.
[18] Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet, 1997, 349(9059): 1144-1145.
[19] del Giudice P, Marty P, Gari-Toussaint M, et al. Ivermectin in elderly patients. Arch Dermatol, 1999,135(3): 351-352.
[20] Youssef MY, Sadaka HA, Eissa MM, et al. Topical application of ivermectin for human ectoparasites. Am J Trop Med Hyg, 1995,53(6): 652-653.
[21] Forstinger C, Kittler H, Binder M. Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol, 1999,41(5 Pt 1):775-777.